Food allergy
Not yet recruitingStudy on the Safety and Tolerability of INP20 for Peanut Allergy in Patients
- Disease:Food allergy
- Substances:–
Spain- Participants:0–17 years · 18–64 years · 65+ years
- Sponsor:Innoup Farma S.L.
Rare diseases
Investigational molecules
Locations

Plaza Cein 5, Noain C, 31110, Spain
Innoup Farma S.L. is active in clinical research for peanut allergy, with a focus on oral treatment approaches designed to address allergic sensitivity and long-term tolerability in affected patients.
The company’s work in this area centers on defining clinically relevant treatment options for allergic disease management.
Innoup Farma S.L. runs clinical trials in conditions such as Food allergy, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.